In the past 52-week period, shares of Cytori Therapeutics, Inc. (NASDAQ:CYTX) have moved within the range of $0.28 to $2.13. On the stock’s most recent trading day, the company’s shares ended the regular session at $0.33, which is 84.51% higher than its 52-week high.
Cytori Therapeutics, Inc. (CYTX) has demonstrated a 20-day simple moving average (SMA) of -13.78%, and a 50-day SMA of -21.36%. This public company’s current market capitalization stands at $10.76 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
When it comes to quarterly financial results, publicly-traded companies usually post earnings and revenue figures that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Cytori Therapeutics, Inc. (CYTX) delivered a 36.39% surprise with its net revenue.
Investors can gain useful insight on institutional ownership within a public company by taking a look at the organization’s most recent 13F filings. Cytori Therapeutics, Inc. (CYTX) has 0 billion shares outstanding currently, 07.41% of which belong to institutional investors.
Additionally, according to the most recent 13F filing from Cytori Therapeutics, Inc. (CYTX), there were 4 new positions totaling 84,085 shares of the company’s stock. There were 3 sold out positions, on the other hand, totaling 1,638,482 shares.Short, Medium and Long Term Indicators
By looking at a stock’s average trade volume – in the short, medium, and long terms – we can gain a better understanding of investor sentiment and trading activity. Cytori Therapeutics, Inc. (CYTX) has had a 20-day average volume of 644,195 shares, with an average of 100% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 1,273,222 shares, with an average of 100% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,048,432 shares with 67% of long-term indicators pointing to Sell.